Is Copiktra available in Poland?

To the best of my knowledge, the drug is not available, although it was registered in May 2021 for use throughout Europe. However, due to the very high cost (based on foreign sources it can be over $ 25,000 - 36,000 euros for a pack of 56 tablets), this drug could be used properly only in the drug program. Decisions on its reimbursement in Poland have not yet been made, but in February 2022 the Agency for Health Technology Assessment and Tariffs issued an opinion in this respect. Copiktra is indicated for the treatment of adults with relapsed or refractory chronic lymphocytic leukaemia and in patients with refractory follicular lymphoma. The drug is introduced after the previous use of at least two treatments, if they do not prove effective. I enclose information that may be of interest to you: https://www.gdziepolek.pl/artykuly/import-docelowy-jak-sprowadzic-lek-z-zagranicy https://www.gdziepolek.pl/kategorie/programy-lekowe-nowoczesne-terapie https://www.gdziepolek.pl/artykuly/jak-zapobiegac-nowotworom